Eisner Mark

Track

Insider profile

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 15% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Eisner Mark's trades of Vir Biotechnology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
322.99
Quantity 96,863
Value US$3,144,952
Transaction date
Planned sale
Price
107.02
Quantity 57,661 -46.2%
Value US$4,469,786
Transaction date
Proposed sale
Price
290.20
Quantity 27,302
Value US$3,111,331
Transaction date
Proposed sale
Price
5.41
Quantity 3,586
Value US$19,400
Transaction date
Proposed sale
Price
5.47
Quantity 6,796
Value US$37,162
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
17.04
Quantity 2,042 -1.2%
Value US$34,792
US FibroGen Inc (FGEN)
Transaction date
Proposed sale
Price
17.04
Quantity 2,042
Value US$34,792
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
18.83
Quantity 1,090 -0.7%
Value US$20,525
US FibroGen Inc (FGEN)
Transaction date
Proposed sale
Price
18.83
Quantity 1,090
Value US$20,525
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
18.78
Quantity 9,182 -5.2%
Value US$172,473
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
20.20
Quantity 6,255 -3.4%
Value US$126,334
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
20.20
Quantity 3,885 -2.1%
Value US$78,467
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
21.16
Quantity 7,363 -4.3%
Value US$155,771
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
21.87
Quantity 1,187 -0.7%
Value US$25,960
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-30 2026-04-30
PrS Proposed sale
96,863
322.99
US$3,144,952 		96,863 322.99 US$3,144,952
2026-02-26 2026-02-25
PlS Planned sale
57,661 -46.2%
107.02
US$4,469,786 		57,661 -46.2% 107.02 US$4,469,786
2026-02-25 2026-02-25
PrS Proposed sale
27,302
290.20
US$3,111,331 		27,302 290.20 US$3,111,331
2026-02-26 2026-02-24
PlS Planned sale
1,616 -1.0%
9.53
US$15,405 		1,616 -1.0% 9.53 US$15,405
2026-02-24 2026-02-24
PrS Proposed sale
1,616
9.53
US$15,405 		1,616 9.53 US$15,405
2026-02-24 2026-02-23
PlS Planned sale
2,089 -1.3%
7.45
US$15,569 		2,089 -1.3% 7.45 US$15,569
2026-02-23 2026-02-23
PrS Proposed sale
2,089
7.45
US$15,569 		2,089 7.45 US$15,569
2025-07-17 2025-07-17
PrS Proposed sale
3,586
5.41
US$19,400 		3,586 5.41 US$19,400
2025-07-17 2025-07-17
PlS Planned sale
3,586 -3.3%
5.47
US$19,629 		3,586 -3.3% 5.47 US$19,629
2025-07-17 2025-07-15
S Sale
6,796 -5.9%
5.47
US$37,162 		6,796 -5.9% 5.47 US$37,162
2025-07-15 2025-07-15
PrS Proposed sale
6,796
5.47
US$37,162 		6,796 5.47 US$37,162
2023-06-09 2023-06-07
US FibroGen Inc (FGEN)
S Sale
2,042 -1.2%
17.04
US$34,792 		2,042 -1.2% 17.04 US$34,792
2023-06-07 2023-06-07
US FibroGen Inc (FGEN)
PrS Proposed sale
2,042
17.04
US$34,792 		2,042 17.04 US$34,792
2023-06-05 2023-06-02
US FibroGen Inc (FGEN)
S Sale
1,090 -0.7%
18.83
US$20,525 		1,090 -0.7% 18.83 US$20,525
2023-06-02 2023-06-02
US FibroGen Inc (FGEN)
PrS Proposed sale
1,090
18.83
US$20,525 		1,090 18.83 US$20,525
2023-04-06 2023-04-04
US FibroGen Inc (FGEN)
S Sale
9,182 -5.2%
18.78
US$172,473 		9,182 -5.2% 18.78 US$172,473
2023-03-10 2023-03-10
US FibroGen Inc (FGEN)
S Sale
6,255 -3.4%
20.20
US$126,334 		6,255 -3.4% 20.20 US$126,334
2023-03-10 2023-03-10
US FibroGen Inc (FGEN)
S Sale
3,885 -2.1%
20.20
US$78,467 		3,885 -2.1% 20.20 US$78,467
2023-03-10 2023-03-08
US FibroGen Inc (FGEN)
S Sale
7,363 -4.3%
21.16
US$155,771 		7,363 -4.3% 21.16 US$155,771
2023-03-06 2023-03-02
US FibroGen Inc (FGEN)
S Sale
1,187 -0.7%
21.87
US$25,960 		1,187 -0.7% 21.87 US$25,960